The New Reality of Peptide Analysis
Kelly Broster of Thermo Fisher Scientific explains why GLP-1 peptides are exposing the limits of traditional analytical workflows
False
Advertisement
Related Content
Biopharma
Business & Trends
Technology & Manufacturing
The Manufacturing Questions Facing Chinese Biotech
September 9, 2026
5 min read
Lonza’s Wayne Wen discusses the growing maturity of China’s drug development and manufacturing ecosystem – and what companies need to compete internationally
Biopharma
Biopharma
Regulation & Standards
China’s Biopharma Homecoming
September 1, 2026
7 min read
Chinese biopharma leaders are returning from the West to build a more confident – and innovative – global industry, says Cyagen’s Lance Han
Biopharma
Biopharma
Breaking Manufacturing Bottlenecks in Nucleic Acid Therapeutics
August 31, 2026
4 min read
New approaches to oligonucleotide production, mRNA design, and supply chain control could help turn promising nucleic acid therapies into scalable commercial products
Biopharma
Technology & Manufacturing
The Hidden Complexity of Stability Storage
August 27, 2026
9 min read
Why preserving samples is a scientific, regulatory, and operational challenge – and what’s at risk when it goes wrong